CXCL1 and cancer: In a recent Cancer Discovery publication, Bianchi et al. unveil a crucial mechanism driving therapeutic resistance in pancreatic ductal adenocarcinoma (PDAC), orchestrated by cell-autonomous Cxcl1 and TNF from polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs).